{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T20:14:57Z","timestamp":1790712897510,"version":"4.1.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,1,29]],"date-time":"2018-01-29T00:00:00Z","timestamp":1517184000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,1,29]],"date-time":"2018-01-29T00:00:00Z","timestamp":1517184000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The pathology of sepsis is typically characterized by an infection and excessive initial inflammation including a cytokine storm, followed by a state of immune suppression or paralysis. This classical view of a two peak kinetic immune response is currently controversially discussed. This study was a sub-study of the randomized clinical Trial SISPCT registered with<jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.clinicaltrials.gov\">www.clinicaltrials.gov<\/jats:ext-link>(NCT00832039, Registration date: 29\/01\/2009). Blood samples from 76 patients with severe sepsis and septic shock were incubated for 48\u2009h at 37\u2009\u00b0C<jats:italic>in vitro<\/jats:italic>with bacterial or fungal recall-antigens or specific mitogen antigens within 24\u2009hours of sepsis onset. Recall-antigen stimulation led to a severe dampening of normal cytokine release. This immunologic anergy was similarly observed after mitogen stimulation. Moreover, patients under hydrocortisone therapy or with lowered arterial oxygen tension had further reductions in cytokine levels upon B- and T-cell mitogen stimulation. This investigation reveals an early onset of immunoparalysis during sepsis. This immune incompetence in mounting an adequate response to further infections includes previously sensitized pathogens, as seen with recall-antigens. Also, the immune-suppressive role of hydrocortisone and low PaO<jats:sub>2<\/jats:sub>is highlighted. Aside from early broad-spectrum antimicrobial therapy, our findings reinforce the need for maximal immunological support and protection against further infections at the onset of sepsis.<\/jats:p>","DOI":"10.1038\/s41598-018-19976-w","type":"journal-article","created":{"date-parts":[[2018,1,23]],"date-time":"2018-01-23T11:33:51Z","timestamp":1516707231000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Early immune anergy towards recall antigens and mitogens in patients at onset of septic shock"],"prefix":"10.1038","volume":"8","author":[{"given":"M.","family":"Feuerecker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Sudhoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Crucian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.-I.","family":"Pagel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Sams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Strewe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Schelling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Briegel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Kaufmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Chouk\u00e8r","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,1,29]]},"reference":[{"key":"19976_CR1","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1586\/eri.12.50","volume":"10","author":"GS Martin","year":"2012","unstructured":"Martin, G. S. Sepsis, severe sepsis and septic shock: changes in incidence, pathogens and outcomes. Expert Rev. Anti. Infect. Ther. 10, 701\u2013706, https:\/\/doi.org\/10.1586\/eri.12.50 (2012).","journal-title":"Expert Rev. Anti. Infect. Ther."},{"key":"19976_CR2","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1056\/NEJMoa022139","volume":"348","author":"GS Martin","year":"2003","unstructured":"Martin, G. S., Mannino, D. M., Eaton, S. & Moss, M. The epidemiology of sepsis in the United States from 1979 through 2000. N. Engl. J. Med. 348, 1546\u20131554, https:\/\/doi.org\/10.1056\/NEJMoa022139 (2003).","journal-title":"N. Engl. J. Med."},{"key":"19976_CR3","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1056\/NEJMra021333","volume":"348","author":"RS Hotchkiss","year":"2003","unstructured":"Hotchkiss, R. S. & Karl, I. E. The pathophysiology and treatment of sepsis. N. Engl. J. Med. 348, 138\u2013150, https:\/\/doi.org\/10.1056\/NEJMra021333 (2003).","journal-title":"N. Engl. J. Med."},{"key":"19976_CR4","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1097\/00003246-200107000-00002","volume":"29","author":"DC Angus","year":"2001","unstructured":"Angus, D. C. et al. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit. Care Med. 29, 1303\u20131310 (2001).","journal-title":"Crit. Care Med."},{"key":"19976_CR5","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1038\/nri2402","volume":"8","author":"D Rittirsch","year":"2008","unstructured":"Rittirsch, D., Flierl, M. A. & Ward, P. A. Harmful molecular mechanisms in sepsis. Nat. Rev. Immunol. 8, 776\u2013787, https:\/\/doi.org\/10.1038\/nri2402 (2008).","journal-title":"Nat. Rev. Immunol."},{"key":"19976_CR6","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1097\/MCC.0b013e32834a4aeb","volume":"17","author":"WJ Wiersinga","year":"2011","unstructured":"Wiersinga, W. J. Current insights in sepsis: from pathogenesis to new treatment targets. Curr. Opin. Crit. Care 17, 480\u2013486, https:\/\/doi.org\/10.1097\/MCC.0b013e32834a4aeb (2011).","journal-title":"Curr. Opin. Crit. Care"},{"key":"19976_CR7","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1182\/blood.V89.5.1612","volume":"89","author":"W Ertel","year":"1997","unstructured":"Ertel, W. et al. Inhibition of the defense system stimulating interleukin-12 interferon-gamma pathway during critical Illness. Blood 89, 1612\u20131620 (1997).","journal-title":"Blood"},{"key":"19976_CR8","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1097\/00003246-199907000-00002","volume":"27","author":"RS Hotchkiss","year":"1999","unstructured":"Hotchkiss, R. S. et al. Apoptotic cell death in patients with sepsis, shock, and multiple organ dysfunction. Crit. Care Med. 27, 1230\u20131251 (1999).","journal-title":"Crit. Care Med."},{"key":"19976_CR9","doi-asserted-by":"publisher","first-page":"4648","DOI":"10.4049\/jimmunol.1201806","volume":"189","author":"MF Osuchowski","year":"2012","unstructured":"Osuchowski, M. F., Craciun, F., Weixelbaumer, K. M., Duffy, E. R. & Remick, D. G. Sepsis chronically in MARS: systemic cytokine responses are always mixed regardless of the outcome, magnitude, or phase of sepsis. J. Immunol. 189, 4648\u20134656, https:\/\/doi.org\/10.4049\/jimmunol.1201806 (2012).","journal-title":"J. Immunol."},{"key":"19976_CR10","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.jinf.2011.08.004","volume":"63","author":"R Huttunen","year":"2011","unstructured":"Huttunen, R. & Aittoniemi, J. New concepts in the pathogenesis, diagnosis and treatment of bacteremia and sepsis. J. Infect. 63, 407\u2013419, https:\/\/doi.org\/10.1016\/j.jinf.2011.08.004 (2011).","journal-title":"J. Infect."},{"key":"19976_CR11","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1001\/jamainternmed.2016.2514","volume":"176","author":"F Bloos","year":"2016","unstructured":"Bloos, F. et al. Effect of Sodium Selenite Administration and Procalcitonin-Guided Therapy on Mortality in Patients With Severe Sepsis or Septic Shock: A Randomized Clinical Trial. JAMA Intern. Med. 176, 1266\u20131276, https:\/\/doi.org\/10.1001\/jamainternmed.2016.2514 (2016).","journal-title":"JAMA Intern. Med."},{"key":"19976_CR12","doi-asserted-by":"publisher","unstructured":"Reinhart, K. et al. Prevention, diagnosis, therapy and follow-up care of sepsis: 1st revision of S-2k guidelines of the German Sepsis Society (Deutsche Sepsis-Gesellschaft e.V. (DSG)) and the German Interdisciplinary Association of Intensive Care andEmergency Medicine (Deutsche Interdisziplinare Vereinigung fur Intensiv- und Notfallmedizin (DIVI)). Ger. Med. Sci.: GMS e-journal 8, Doc14, https:\/\/doi.org\/10.3205\/000103 (2010).","DOI":"10.3205\/000103"},{"key":"19976_CR13","unstructured":"Jacob, S. & Cory, F. In Common Surgical Diseases (eds J. A. Myers, K. W. Millikan, & T. J. Saclarides) Ch. 97, 391\u2013394 (Springer New York, 2008)."},{"key":"19976_CR14","unstructured":"respiratoryupdate. Levels of Hypoxemia, http:\/\/www.respiratoryupdate.com\/members\/Levels_of_Hypoxemia.cfm (2015)."},{"key":"19976_CR15","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1111\/cei.12049","volume":"172","author":"M Feuerecker","year":"2013","unstructured":"Feuerecker, M. et al. A corticoid-sensitive cytokine release assay for monitoring stress-mediated immune modulation. Clin. Exp. Immunol. 172, 290\u2013299, https:\/\/doi.org\/10.1111\/cei.12049 (2013).","journal-title":"Clin. Exp. Immunol."},{"key":"19976_CR16","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1164\/rccm.201301-0036CP","volume":"187","author":"J Leentjens","year":"2013","unstructured":"Leentjens, J., Kox, M., van der Hoeven, J. G., Netea, M. G. & Pickkers, P. Immunotherapy for the adjunctive treatment of sepsis: from immunosuppression to immunostimulation. Time for a paradigm change? Am. J. Respir. Crit. Care Med. 187, 1287\u20131293, https:\/\/doi.org\/10.1164\/rccm.201301-0036CP (2013).","journal-title":"Time for a paradigm change? Am. J. Respir. Crit. Care Med."},{"key":"19976_CR17","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1684\/ecn.2011.0281","volume":"22","author":"E Tamayo","year":"2011","unstructured":"Tamayo, E. et al. Pro- and anti-inflammatory responses are regulated simultaneously from the first moments of septic shock. Eur. Cytokine Netw. 22, 82\u201387, https:\/\/doi.org\/10.1684\/ecn.2011.0281 (2011).","journal-title":"Eur. Cytokine Netw."},{"key":"19976_CR18","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1016\/j.imbio.2011.10.019","volume":"217","author":"AR Novotny","year":"2012","unstructured":"Novotny, A. R. et al. Mixed antagonist response and sepsis severity-dependent dysbalance of pro- and anti-inflammatory responses at the onset of postoperative sepsis. Immunobiology 217, 616\u2013621, https:\/\/doi.org\/10.1016\/j.imbio.2011.10.019 (2012).","journal-title":"Immunobiology"},{"key":"19976_CR19","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1097\/00024382-200013020-00004","volume":"13","author":"DG Remick","year":"2000","unstructured":"Remick, D. G., Newcomb, D. E., Bolgos, G. L. & Call, D. R. Comparison of the mortality and inflammatory response of two models of sepsis: lipopolysaccharide vs. cecal ligation and puncture. Shock 13, 110\u2013116 (2000).","journal-title":"Shock"},{"key":"19976_CR20","doi-asserted-by":"publisher","unstructured":"Frazier, W. J. & Hall, M. W. Immunoparalysis and adverse outcomes from critical illness. Pediatr. Clin. North Am. 55, 647\u2013668, xi, https:\/\/doi.org\/10.1016\/j.pcl.2008.02.009 (2008).","DOI":"10.1016\/j.pcl.2008.02.009"},{"key":"19976_CR21","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/nature08780","volume":"464","author":"Q Zhang","year":"2010","unstructured":"Zhang, Q. et al. Circulating mitochondrial DAMPs cause inflammatory responses to injury. Nature 464, 104\u2013107, https:\/\/doi.org\/10.1038\/nature08780 (2010).","journal-title":"Nature"},{"key":"19976_CR22","doi-asserted-by":"publisher","first-page":"2957","DOI":"10.1001\/jama.1993.03510240069035","volume":"270","author":"JR Le Gall","year":"1993","unstructured":"Le Gall, J. R., Lemeshow, S. & Saulnier, F. A new Simplified Acute Physiology Score (SAPS II) based on a European\/North American multicenter study. JAMA 270, 2957\u20132963 (1993).","journal-title":"JAMA"},{"key":"19976_CR23","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1097\/00003246-198510000-00009","volume":"13","author":"WA Knaus","year":"1985","unstructured":"Knaus, W. A., Draper, E. A., Wagner, D. P. & Zimmerman, J. E. APACHE II: a severity of disease classification system. Crit. Care Med. 13, 818\u2013829 (1985).","journal-title":"Crit. Care Med."},{"key":"19976_CR24","doi-asserted-by":"crossref","first-page":"5556","DOI":"10.4049\/jimmunol.150.12.5556","volume":"150","author":"A Haziot","year":"1993","unstructured":"Haziot, A., Tsuberi, B. Z. & Goyert, S. M. Neutrophil CD14: biochemical properties and role in the secretion of tumor necrosis factor-alpha in response to lipopolysaccharide. J. Immunol. 150, 5556\u20135565 (1993).","journal-title":"J. Immunol."},{"key":"19976_CR25","doi-asserted-by":"publisher","first-page":"9196","DOI":"10.1073\/pnas.0600462103","volume":"103","author":"AF McGettrick","year":"2006","unstructured":"McGettrick, A. F. et al. Trif-related adapter molecule is phosphorylated by PKC{epsilon} during Toll-like receptor 4 signaling. Proc. Natl. Acad. Sci. USA 103, 9196\u20139201, https:\/\/doi.org\/10.1073\/pnas.0600462103 (2006).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"19976_CR26","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1097\/CCM.0b013e31827e83af","volume":"41","author":"RP Dellinger","year":"2013","unstructured":"Dellinger, R. P. et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med. 41, 580\u2013637, https:\/\/doi.org\/10.1097\/CCM.0b013e31827e83af (2013).","journal-title":"Crit Care Med."},{"key":"19976_CR27","doi-asserted-by":"publisher","first-page":"116","DOI":"10.2119\/2007-00075.Chouker","volume":"14","author":"A Chouker","year":"2008","unstructured":"Chouker, A. et al. Critical role of hypoxia and A2A adenosine receptors in liver tissue-protecting physiological anti-inflammatory pathway. Mol. Med. 14, 116\u2013123, https:\/\/doi.org\/10.2119\/2007-00075.Chouker (2008).","journal-title":"Mol. Med."},{"key":"19976_CR28","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1097\/01.shk.0000238066.00074.90","volume":"27","author":"I Kaufmann","year":"2007","unstructured":"Kaufmann, I. et al. Effects of adenosine on functions of polymorphonuclear leukocytes from patients with septic shock. Shock 27, 25\u201331, https:\/\/doi.org\/10.1097\/01.shk.0000238066.00074.9000024382-200701000-00005 (2007).","journal-title":"Shock"},{"key":"19976_CR29","doi-asserted-by":"publisher","unstructured":"Thiel, M. et al. Oxygenation inhibits the physiological tissue-protecting mechanism and thereby exacerbates acute inflammatory lung injury. PLoS Biol. 3, e174, 04-PLBI-RA-0506R3, https:\/\/doi.org\/10.1371\/journal.pbio.0030174 (2005).","DOI":"10.1371\/journal.pbio.0030174"},{"key":"19976_CR30","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1056\/NEJMra0910283","volume":"364","author":"HK Eltzschig","year":"2011","unstructured":"Eltzschig, H. K. & Carmeliet, P. Hypoxia and inflammation. N. Engl. J. Med. 364, 656\u2013665, https:\/\/doi.org\/10.1056\/NEJMra0910283 (2011).","journal-title":"N. Engl. J. Med."},{"key":"19976_CR31","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1002\/eji.200939897","volume":"40","author":"M Nowak","year":"2010","unstructured":"Nowak, M. et al. The A2aR adenosine receptor controls cytokine production in iNKT cells. Eur. J. Immunol. 40, 682\u2013687, https:\/\/doi.org\/10.1002\/eji.200939897 (2010).","journal-title":"Eur. J. Immunol."},{"key":"19976_CR32","doi-asserted-by":"crossref","unstructured":"Linden, J. Adenosine in tissue protection and tissue regeneration. Mol. Pharmacol. 67, 1385\u20131387, 105.011783\/10.1124\/mol.105.011783 (2005).","DOI":"10.1124\/mol.105.011783"},{"key":"19976_CR33","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1093\/ndt\/gfm610","volume":"23","author":"M Oppert","year":"2008","unstructured":"Oppert, M. et al. Acute renal failure in patients with severe sepsis and septic shock\u2013a significant independent risk factor for mortality: results from the German Prevalence Study. Nephrol. Dial. Transplant. 23, 904\u2013909, https:\/\/doi.org\/10.1093\/ndt\/gfm610 (2008).","journal-title":"Nephrol. Dial. Transplant."},{"key":"19976_CR34","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1111\/apha.12798","volume":"219","author":"SB Anderberg","year":"2017","unstructured":"Anderberg, S. B., Luther, T. & Frithiof, R. Physiological aspects of Toll-like receptor 4 activation in sepsis-induced acute kidney injury. Acta physiol. 219, 573\u2013588, https:\/\/doi.org\/10.1111\/apha.12798 (2017).","journal-title":"Acta physiol."},{"key":"19976_CR35","doi-asserted-by":"publisher","unstructured":"Liu, V. X. et al. The Timing of Early Antibiotics and Hospital Mortality in Sepsis. Am. J. Respir. Crit. Care Med., https:\/\/doi.org\/10.1164\/rccm.201609-1848OC (2017).","DOI":"10.1164\/rccm.201609-1848OC"},{"key":"19976_CR36","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1038\/nm0509-496","volume":"15","author":"RS Hotchkiss","year":"2009","unstructured":"Hotchkiss, R. S., Coopersmith, C. M., McDunn, J. E. & Ferguson, T. A. The sepsis seesaw: tilting toward immunosuppression. Nat.med. 15, 496\u2013497, https:\/\/doi.org\/10.1038\/nm0509-496 (2009).","journal-title":"Nat.med."},{"issue":"Suppl 2","key":"19976_CR37","doi-asserted-by":"publisher","first-page":"S70","DOI":"10.1016\/j.ijantimicag.2010.11.008","volume":"36","author":"SM Opal","year":"2010","unstructured":"Opal, S. M. New perspectives on immunomodulatory therapy for bacteraemia and sepsis. Int. J. Antimicrob. Agents 36(Suppl 2), S70\u201373, https:\/\/doi.org\/10.1016\/j.ijantimicag.2010.11.008 (2010).","journal-title":"Int. J. Antimicrob. Agents"},{"key":"19976_CR38","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1097\/QCO.0000000000000080","volume":"27","author":"GK Huang","year":"2014","unstructured":"Huang, G. K., Stewardson, A. J. & Grayson, M. L. Back to basics: hand hygiene and isolation. Curr. Opin. Infect. Dis. 27, 379\u2013389, https:\/\/doi.org\/10.1097\/QCO.0000000000000080 (2014).","journal-title":"Curr. Opin. Infect. Dis."},{"key":"19976_CR39","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1056\/NEJM198709103171101","volume":"317","author":"RC Bone","year":"1987","unstructured":"Bone, R. C. et al. A controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock. N. Engl. J. Med. 317, 653\u2013658, https:\/\/doi.org\/10.1056\/NEJM198709103171101 (1987).","journal-title":"N. Engl. J. Med."},{"key":"19976_CR40","doi-asserted-by":"publisher","first-page":"2362","DOI":"10.1001\/jama.2009.815","volume":"301","author":"D Annane","year":"2009","unstructured":"Annane, D. et al. Corticosteroids in the treatment of severe sepsis and septic shock in adults: a systematic review. JAMA Intern. Med. 301, 2362\u20132375, https:\/\/doi.org\/10.1001\/jama.2009.815 (2009).","journal-title":"JAMA Intern. Med."},{"key":"19976_CR41","doi-asserted-by":"publisher","unstructured":"Annane, D. et al. Corticosteroids for treating sepsis. Cochrane Database Syst. Rev., CD002243, https:\/\/doi.org\/10.1002\/14651858.CD002243.pub3 (2015).","DOI":"10.1002\/14651858.CD002243.pub3"},{"key":"19976_CR42","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1517\/14728214.2016.1132700","volume":"21","author":"N Heming","year":"2016","unstructured":"Heming, N., Lamothe, L., Ambrosi, X. & Annane, D. Emerging drugs for the treatment of sepsis. Expert Opin. Emerg. Drugs 21, 27\u201337, https:\/\/doi.org\/10.1517\/14728214.2016.1132700 (2016).","journal-title":"Expert Opin. Emerg. Drugs"},{"key":"19976_CR43","doi-asserted-by":"publisher","first-page":"e2044","DOI":"10.1097\/MD.0000000000002044","volume":"94","author":"B Mathias","year":"2015","unstructured":"Mathias, B., Szpila, B. E., Moore, F. A., Efron, P. A. & Moldawer, L. L. A Review of GM-CSF Therapy in Sepsis. Medicine 94, e2044, https:\/\/doi.org\/10.1097\/MD.0000000000002044 (2015).","journal-title":"Medicine"},{"key":"19976_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/srep10539","volume":"5","author":"A Mansur","year":"2015","unstructured":"Mansur, A. et al. Chronic kidney disease is associated with a higher 90-day mortality than other chronic medical conditions in patients with sepsis. Sci. rep. 5, 10539, https:\/\/doi.org\/10.1038\/srep10539 (2015).","journal-title":"Sci. rep."},{"key":"19976_CR45","doi-asserted-by":"publisher","first-page":"114","DOI":"10.12688\/f1000research.2-114.v1","volume":"2","author":"E Kelly","year":"2013","unstructured":"Kelly, E. et al. Comparison of arterial and venous blood biomarker levels in chronic obstructive pulmonary disease. F1000Res 2, 114, https:\/\/doi.org\/10.12688\/f1000research.2-114.v1 (2013).","journal-title":"F1000Res"},{"key":"19976_CR46","first-page":"813","volume":"10","author":"S Fernandez-Serrano","year":"2003","unstructured":"Fernandez-Serrano, S. et al. Molecular inflammatory responses measured in blood of patients with severe community-acquired pneumonia. Clin Diagn Lab Immunol 10, 813\u2013820 (2003).","journal-title":"Clin Diagn Lab Immunol"},{"key":"19976_CR47","doi-asserted-by":"publisher","first-page":"1922","DOI":"10.1111\/jth.12370","volume":"11","author":"B Shah","year":"2013","unstructured":"Shah, B. et al. Comparison of platelet activity measurements by use of arterial and venous blood sampling. Journal of thrombosis and haemostasis: JTH 11, 1922\u20131924, https:\/\/doi.org\/10.1111\/jth.12370 (2013).","journal-title":"Journal of thrombosis and haemostasis: JTH"},{"key":"19976_CR48","unstructured":"Sepsis, K. http:\/\/clinicaltrials.gov\/show\/NCT00832039."},{"key":"19976_CR49","first-page":"343","volume":"71","author":"N Suzuki","year":"1988","unstructured":"Suzuki, N. & Sakane, T. Mechanism of T cell-derived helper factor production upon stimulation with pokeweed mitogen in humans. Clin. Exp. Immunol. 71, 343\u2013349 (1988).","journal-title":"Clin. Exp. Immunol."},{"key":"19976_CR50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0065-2776(08)60720-8","volume":"32","author":"TA Waldmann","year":"1982","unstructured":"Waldmann, T. A. & Broder, S. Polyclonal B-cell activators in the study of the regulation of immunoglobulin synthesis in the human system. Adv. Immunol. 32, 1\u201363 (1982).","journal-title":"Adv. Immunol."},{"key":"19976_CR51","doi-asserted-by":"publisher","first-page":"2201","DOI":"10.1006\/jmcc.1998.0780","volume":"30","author":"EK Iliodromitis","year":"1998","unstructured":"Iliodromitis, E. K. et al. The PKC activator PMA preconditions rabbit heart in the presence of adenosine receptor blockade: is 5\u2032-nucleotidase important? J. Mol. Cell. Cardiol. 30, 2201\u20132211, https:\/\/doi.org\/10.1006\/jmcc.1998.0780 (1998).","journal-title":"J. Mol. Cell. Cardiol."},{"key":"19976_CR52","doi-asserted-by":"crossref","first-page":"3439","DOI":"10.4049\/jimmunol.135.5.3439","volume":"135","author":"J Nishihira","year":"1985","unstructured":"Nishihira, J. & O\u2019Flaherty, J. T. Phorbol myristate acetate receptors in human polymorphonuclear neutrophils. J. Immunol. 135, 3439\u20133447 (1985).","journal-title":"J. Immunol."},{"key":"19976_CR53","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1002\/eji.200323843","volume":"33","author":"M Masilamani","year":"2003","unstructured":"Masilamani, M., Kassahn, D., Mikkat, S., Glocker, M. O. & Illges, H. B cell activation leads to shedding of complement receptor type II (CR2\/CD21). Eur. J. Immunol. 33, 2391\u20132397, https:\/\/doi.org\/10.1002\/eji.200323843 (2003).","journal-title":"Eur. J. Immunol."},{"key":"19976_CR54","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1084\/jem.145.2.460","volume":"145","author":"JL Touraine","year":"1977","unstructured":"Touraine, J. L. et al. Phorbol myristate acetate: a mitogen selective for a T-lymphocyte subpopulation. J. Exp. Med. 145, 460\u2013465 (1977).","journal-title":"J. Exp. Med."},{"key":"19976_CR55","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/S0022-1759(03)00010-3","volume":"275","author":"A Trickett","year":"2003","unstructured":"Trickett, A. & Kwan, Y. L. T cell stimulation and expansion using anti-CD3\/CD28 beads. J. Immunol. Methods 275, 251\u2013255 (2003).","journal-title":"J. Immunol. Methods"},{"key":"19976_CR56","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1126\/science.282.5396.2085","volume":"282","author":"A Poltorak","year":"1998","unstructured":"Poltorak, A. et al. Defective LPS signaling in C3H\/HeJ and C57BL\/10ScCr mice: mutations in Tlr4 gene. Science 282, 2085\u20132088 (1998).","journal-title":"Science"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-19976-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-19976-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-19976-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,3]],"date-time":"2024-07-03T12:29:26Z","timestamp":1720009766000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-19976-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,29]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["19976"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-19976-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,29]]},"assertion":[{"value":"31 July 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"1754"}}